1. Home
  2. SCNX vs MLEC Comparison

SCNX vs MLEC Comparison

Compare SCNX & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

N/A

Current Price

$0.18

Market Cap

16.2M

Sector

Health Care

ML Signal

N/A

Logo Moolec Science SA

MLEC

Moolec Science SA

N/A

Current Price

$4.76

Market Cap

5.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SCNX
MLEC
Founded
2010
2008
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
5.0M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
SCNX
MLEC
Price
$0.18
$4.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 612.4K
20.6K
Earning Date
11-12-2026
10-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,831,778.00
N/A
Revenue This Year
$1,009.57
$20.42
Revenue Next Year
$259.51
$30.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 30.72
N/A
52 Week Low
$0.24
$0.21
52 Week High
$2.60
$23.22

Technical Indicators

Market Signals
Indicator
SCNX
MLEC
Relative Strength Index (RSI) 13.12 N/A
Support Level N/A N/A
Resistance Level $0.43 N/A
Average True Range (ATR) 0.02 0.00
MACD -0.01 0.00
Stochastic Oscillator 1.80 0.00

Price Performance

Historical Comparison
SCNX
MLEC

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Share on Social Networks: